Mission Statement
SimuGen's passion is knowledge innovation. We are driven by our clear customer need for intuitive and reliable decision making in drug discovery.
"[In drug Development] we are using the tools of the last century to evaluate this century's advances".
The FDA Critical Path Initiative and Its Influence on New Drug Development - Janet Woodcock and Raymond Woosley
SimuGen is a venture-backed pharmacogenomics company focused on predicting human toxicity early on in drug development
